Bruker Corporation

As of June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh carries a market capitalization of 50.03B, placing it among publicly traded companies globally. Its enterprise value stands at 58.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh has 1.63B shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.76, and the price-to-book ratio stands at 4.06.

As of June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh trades at an EV/EBITDA multiple of 56.82 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.24 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 58.59B versus a market cap of 50.03B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 74.92, indicating elevated leverage, while an interest coverage ratio of 3.24 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh posted a negative return on equity (ROE) of -5.11, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.15, reflecting losses generated across the asset base. The company generates approximately 1.62M in revenue per employee across its workforce of 11,162.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.60 indicates how many times Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh recorded 208.83M in income tax expense. The company reported a pretax loss of -115.79M and -368.03M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on September 16, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh's stock has gained approximately 83.35% over the past 52 weeks. The 50-day moving average sits at 24.88, while the 200-day moving average is 27.25.

Over the twelve months ended June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh generated 18.09B in revenue and converted that into -368.03M in net income, yielding earnings per share of -0.20. EBITDA reached 1.03B, while operating income came in at 1.37B.

As of June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh holds 1.15B in cash and equivalents against 9.43B in total debt, resulting in a net debt position of 8.48B. Total book value stands at 12.31B, with working capital of 5.27B providing operational flexibility.

Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh produced 984.18M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -498.81M in capital expenditures, free cash flow totaled 485.37M - equivalent to 0.30 per share.

Over the twelve months ended June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh posted a gross margin of 46.42, reflecting its pricing power and cost economics. The operating margin of 7.60 and net profit margin of -2.03 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh paid dividends of 0.17 per share. The dividend payout ratio of -20.32 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 0.97, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -0.36, meaning Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Bruker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh has an Altman Z-Score of 3.95, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.